Our science

Devoted. Compassionate. Patient. Tenacious. These are
the qualities that define our team of innovators.

What does it take to make life-changing therapies for rare diseases?

Fulfilling our mission to help people live healthier, happier lives takes an unwavering devotion to scientific research and development. It takes a spark of innovation, kindled to a blazing fire of discovery. It takes empathy and compassion from patient-focused emissaries to carefully place scientific advancement into the hands of the people who need it the most: patients with high unmet medical need. And, in the field of rare disease science, it takes patience and tenacity.

“Having served in both our science and patient focused fields, I have come to understand that having empathy for the patient is critical in the development of therapies to treat rare diseases.”

NS Pharma President Yukiteru Sugiyama, Ph.D. 

NS Pharma brings life-changing therapies
to patients with rare diseases in the United States

Drug discovery and clinical development at NS Pharma happens in concert with our parent company, Nippon Shinyaku. We work in the fields of intractable and rare diseases – specifically neurology and pulmonology. We develop the science of small molecule and nucleic acid drugs. And we nurture this science through global clinical trials, working ethically and in compliance with regulatory bodies.

Our science is focused where it counts

At NS Pharma, we’re working to develop therapies for unmet medical need. We have razor sharp focus on treating rare diseases.

Exon-skipping science
Exon-skipping has the potential to
treat Duchenne muscular dystrophy.

Explore

JAK1 inhibition science
JAK1 inhibition is being developed
to treat EGPA, a type of vasculitis.

Explore